2.76

1.78% -0.05

Galectin Therapeutics Inc (GALT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.81

Aprire:

$2.72

Volume 24 ore:

156.58K

Relative Volume:

0.32

Capitalizzazione di mercato:

$177.94M

Reddito:

Utile/perdita netta:

$-45.08M

Rapporto P/E:

-3.7808

EPS:

-0.73

Flusso di cassa netto:

$-33.68M

1 W Prestazione:

-1.43%

1M Prestazione:

-10.10%

6M Prestazione:

-24.80%

1 anno Prestazione:

+112.31%

Intervallo 1D:

$2.7001

$2.81

Intervallo di 1 settimana:

$2.61

$2.88

Portata 52W:

$1.12

$7.13

Galectin Therapeutics Inc Stock (GALT) Company Profile

Nome

Galectin Therapeutics Inc

Settore

Healthcare (1111)

Industria

Biotechnology (622)

Telefono

678-620-3186

Indirizzo

4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA

Dipendente

Cinguettio

@galectingalt

Prossima data di guadagno

2025-03-31

Ultimi documenti SEC

GALT's Discussions on Twitter

Compare GALT vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GALT Galectin Therapeutics Inc	2.76	181.17M	0	-45.08M	-33.68M	-0.73
VRTX Vertex Pharmaceuticals Inc	491.47	117.98B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	803.17	82.85B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	821.96	51.58B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	314.40	40.75B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.07	38.33B	4.98B	69.60M	525.67M	0.5198

Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-06-17	Ripresa	H.C. Wainwright	Buy
2020-08-13	Reiterato	H.C. Wainwright	Buy
2019-02-13	Iniziato	B. Riley FBR	Buy
2017-12-07	Reiterato	H.C. Wainwright	Buy
2017-11-28	Reiterato	H.C. Wainwright	Buy
2017-10-19	Iniziato	ROTH Capital	Buy
2017-03-30	Aggiornamento	H.C. Wainwright	Neutral → Buy
2016-10-03	Downgrade	FBR & Co.	Outperform → Mkt Perform
2016-09-29	Downgrade	H.C. Wainwright	Buy → Neutral
2016-09-28	Downgrade	ROTH Capital	Buy → Sell
2016-03-28	Ripresa	H.C. Wainwright	Buy
2015-09-21	Iniziato	H.C. Wainwright	Buy
2014-08-01	Downgrade	Aegis Capital	Buy → Hold
2014-07-30	Reiterato	MLV & Co	Buy
2014-07-29	Reiterato	MLV & Co	Buy
2014-04-02	Reiterato	MLV & Co	Buy
2014-02-10	Reiterato	Aegis Capital	Buy
2014-01-09	Reiterato	Aegis Capital	Buy
2013-12-03	Iniziato	MLV & Co	Buy
2013-08-19	Reiterato	Aegis Capital	Buy

Mostra tutto

Galectin Therapeutics Inc Borsa (GALT) Ultime notizie

Feb 12, 2026

Will Galectin Therapeutics Inc. stock deliver long term returns2025 Volatility Report & Safe Capital Allocation Plans - mfd.ru

Feb 12, 2026

Feb 11, 2026

What’s the outlook for Galectin Therapeutics Inc.’s sectorMarket Growth Review & Fast Exit/Entry Strategy Plans - mfd.ru

Feb 11, 2026

Feb 09, 2026

Buy Signal: Whats the outlook for Galectin Therapeutics Incs sectorPortfolio Return Report & AI Based Trade Execution Alerts - baoquankhu1.vn

Feb 09, 2026

Feb 06, 2026

Short Covering: How is MLKN managing supply chain issues2025 Trading Recap & Fast Moving Stock Watchlists - baoquankhu1.vn

Feb 06, 2026

Feb 01, 2026

Aug Chart Watch: Is Galectin Therapeutics Inc gaining market shareJuly 2025 Recap & Accurate Intraday Trade Tips - baoquankhu1.vn

Feb 01, 2026

Jan 30, 2026

Galectin Therapeutics Inc.'s (NASDAQ:GALT) market cap dropped US$39m last week; Individual investors bore the brunt - simplywall.st

Jan 30, 2026

Jan 26, 2026

Can Galectin Therapeutics Inc expand into new marketsJobs Report & Real-Time Volume Analysis - baoquankhu1.vn

Jan 26, 2026

Meme Stocks: Will Galectin Therapeutics Inc outperform its industry peersMarket Activity Report & Expert Approved Momentum Ideas - baoquankhu1.vn

Jan 26, 2026

Jan 23, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc.GALT - yourwyominglink.com

Jan 23, 2026

Jan 22, 2026

Galectin Therapeutics Inc.'s (NASDAQ:GALT) top owners are retail investors with 55% stake, while 20% is held by insiders - Yahoo Finance

Jan 22, 2026

Galectin Therapeutics Approves Retention Bonuses for Key Executives - The Globe and Mail

Jan 22, 2026

Jan 20, 2026

Moving Averages: What is the Moat Score of WVVIPBuy Signal & Fast Entry and Exit Trade Plans - baoquankhu1.vn

Jan 20, 2026

Analysis Recap: Can Galectin Therapeutics Inc be the next market leaderTrade Entry Report & Smart Investment Allocation Insights - baoquankhu1.vn

Jan 20, 2026

Portfolio Update: Is DNAWS a potential multi baggerEarnings Beat & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn

Jan 20, 2026

Jan 19, 2026

Galectin Therapeutics Inc. (NASDAQ:GALT) Short Interest Update - MarketBeat

Jan 19, 2026

Jan 15, 2026

Galectin Therapeutics Under Investigation, Stock Plummets 28.9% - Intellectia AI

Jan 15, 2026

Is Galectin Therapeutics Inc. gaining market shareJuly 2025 Analyst Calls & Safe Entry Point Identification - baoquankhu1.vn

Jan 15, 2026

Jan 14, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Galectin Therapeutics Inc. (GALT) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jan 14, 2026

Insider Buy: Can BROG navigate macro headwindsWeekly Investment Summary & Real-Time Volume Trigger Notifications - baoquankhu1.vn

Jan 14, 2026

Jan 13, 2026

Growth Review: Is Galectin Therapeutics Inc stock affected by interest rate hikesQuarterly Earnings Report & Daily Growth Stock Investment Tips - Bộ Nội Vụ

Jan 13, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Galectin Therapeutics Inc. (GALT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Jan 13, 2026